


Technical Sentiment Analysis for Franklin Genomic Advancements ETF (HELX). As of 2026-05-04, Franklin Genomic Advancements ETF (HELX) is exhibiting a Neutral technical sentiment. Our proprietary analysis, which aggregates 10 technical signals, shows that 5 indicators are flashing buy, while 5 are indicating sell.
Momentum Indicators: RSI, MACD & Overbought/Oversold Status. Currently, the Relative Strength Index (RSI) for HELX stands at 48.93, which suggests a Neutral condition. Meanwhile, the MACD (12, 26) indicator is at -0.02, providing a Sell signal for short-term momentum. Other oscillators like the Stochastic Oscillator at 32.94 and the Commodity Channel Index (CCI) at -40.9 further confirm a -1.39 outlook for the ETF.
Support, Resistance & Moving Averages. From a structural perspective, HELX is trading above its 60-day moving average of $33.57 and above its 200-day long-term moving average of $33.44. Key price levels to watch include the immediate resistance at $34.63 and strong support at $32.5. A break above $34.63 could signal a bull continuation, while falling below $32.5 may test the next Fibonacci floor at $31.47.
| Name | S3 | S2 | S1 | Pivot Points | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Classic | 30.37 | 31.47 | 32.5 | 33.6 | 34.63 | 35.73 | 36.75 |
| Fibonacci | 31.47 | 32.28 | 32.78 | 33.6 | 34.41 | 34.91 | 35.73 |
2026-05-04
| Name | Value |
|---|---|
| Relative Strength Index (RSI) | 48.93 |
| Stochastic Oscillator | 32.94 |
| Stochastic RSI | 23.89 |
| Commodity Channel Index (CCI) | -40.9 |
| Awesome Oscillator | -0.05 |
| Momentum | -1.39 |
| MACD | -0.02 |
2026-05-04
| Period | Simple | Signal |
|---|---|---|
| 5-Day | 33.18 | Buy |
| 10-Day | 33.52 | Buy |
| 20-Day | 33.74 | Sell |
| 60-Day | 33.57 | Buy |
| 200-Day | 33.44 | Buy |
| 250-Day | 32.15 | Buy |